Study the Amelioration Efficacy of a Polyherbal Spray for the Treatment of Osteoarthritic Pain and Inflammation in Dogs and Cats

International Journal of Veterinary Science

© 2025 by SSRG - IJVS Journal

Volume 11 Issue 2

Year of Publication : 2025

Authors : Rohit K, Ravikumar B.R, Bhagwat VG, Varun Kumar K

10.14445/24550868/IJVS-V11I2P101

How to Cite?

Rohit K, Ravikumar B.R, Bhagwat VG, Varun Kumar K, "Study the Amelioration Efficacy of a Polyherbal Spray for the Treatment of Osteoarthritic Pain and Inflammation in Dogs and Cats," SSRG International Journal of Veterinary Science, vol. 11,  no. 2, pp. 1-5, 2025. Crossref, https://doi.org/10.14445/24550868/IJVS-V11I2P101

Abstract:

The study evaluated the amelioration effectiveness of polyherbal spray (PHS) in treating osteoarthritic pain and inflammation in dogs and cats. The study involved 26 animals aged 1.0-8.0 years who were diagnosed with pain and swelling due to osteoarthritis disorders. The animals were treated with PHS for 7 consecutive days or until complete recovery. The assessment parameters included pain, swelling, edema reduction, activity level, recovery time, and product performance. The results showed significant reductions in pain, swelling, edema, activity level scores, and recovery time. The mean product performance score was 3.92. After 4 consecutive days of twice-a-day treatment, the dogs and cats experienced complete relief from osteoarthritic pain and inflammation. The study recommends PHS as a complementary prophylactic safe therapy alongside standard treatment for these conditions.

Keywords:

Cats, Dogs, Osteoarthritic pain, Pain, and Polyherbal spray.

References:

[1] Peter Hellyer et al., “AAHA/AAFP Pain Management Guidelines for Dogs and Cats,” Journal of Feline Medicine and Surgery, vol. 9, no. 6, pp. 466–480, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Peter Hellyer, “American College of Veterinary Anesthesiologists’ Position Paper on the Treatment of Pain in Animals,” Journal of American Veterinary Medical Associations, vol. 213, no. 5, pp. 628-630, 1998.
[Google Scholar] [Publisher Link]
[3] Karol A. Mathews, “Pain Assessment and General Approach to Management,” Veterinary Clinics: Small Animal Practice, vol. 30, no. 4, pp. 729-755, 2000.
[Google Scholar] [Publisher Link]
[4] Sheilah A. Robertson, “Managing Pain in Feline Patients,” Veterinary Clinics: North America Small Animal Practice, vol. 38, no. 6, pp. 1267-1290, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[5] B. Duncan Lascelles, and Robertson Sheilah, “DJD-Associated Pain in Cats: What can we do to Promote Patient Comfort?,” Journal of Feline Medicine and Surgery, vol. 12, no. 3, pp. 200-212, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[6] Robertson Sheilah, and B. Duncan X Lascelles, “Long-Term Pain in Cats: How much do we know about this Important Welfare Issue?,” Journal of Feline Medicine and Surgery, vol. 12, no. 3, pp. 188–199, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[7] C.M. Mortellaro, “Pathophysiology of Osteoarthritis,” Veterinary Research Communications, vol. 27, pp. 75-78, 2003.
[CrossRef] [Google Scholar] [Publisher Link]
[8] Chris Pasquini, Thomas Leslie Spurgeon, and Susan Pasquini, Anatomy of Domestic Animals Systemic & Regional Approach, Sudz Publishing, pp. 1-678, 2007.
[Google Scholar] [Publisher Link]
[9] Stephanie D. Bland, “Canine Osteoarthritis and Treatments: A Review,” Veterinary Science Development, vol. 5, no. 2, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[10] Katharine L. Anderson et al., “Prevalence, Duration and Risk Factors for Appendicular Osteoarthritis in a UK Dog Population Under Primary Veterinary Care,” Scientific Reports, vol. 8, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[11] L.S. Slingsby, and A.E. Waterman-Pearson, “Postoperative Analgesia in the Cat after Ovariohysterectomy by Use of Carprofen, Ketoprofen, Meloxicam or Tolfenamic Acid,” Journal of Small Animal Practice, vol. 41, no. 10, pp. 447–450, 2000.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Gwendolyn L. Garroll, Lisa B. Howe, and Kurt D. Peterson, “Analgesic Efficacy of Preoperative Administration of Meloxicam or Butorphanol in Onychectomized Cats,” Journal of American Veterinary Medical Association, vol. 226, no. 6, pp. 913-919, 2005.
[Google Scholar] [Publisher Link]
[13] Polly M. Taylor, Sheilah A. Robertson, and Michael J. Dixon, “Evaluation of the Use of Thermal Thresholds to Investigate NSAID Analgesia in a Model of Inflammatory Pain in Cats,” Journal of Feline Medicine and Surgery, vol. 9, no. 4, pp. 313–318, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Javier Benito-De-La-Vibora et al., “Efficacy of Tolfenamic Acid and Meloxicam in the Control of Postoperative Pain Following Ovariohysterectomy in the Cat,” Veterinary Anaesthesia and Analgesia, vol. 35, no. 6, pp. 501–510, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[15] Josef S. Smolen et al., “EULAR Recommendations for the Management of Rheumatoid Arthritis with Synthetic and Biological Disease Modifying Antirheumatic Drugs: 2013 Update,” Annals of the Rheumatic Diseases, vol. 73, no. 3, pp. 492-509, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Andrea Matucci et al., “Influence of Anti-TNF Immunogenicity on Safety in Rheumatic Disease: A Narrative Review,” Expert Opinion on Drug Safety, vol. 15, no. 1, pp. 3-10, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Vanderlea Poeys Cabral et al., “Severe Infection in Patients with Rheumatoid Arthritis Taking Anakinra, Rituximab, or Abatacept: A Systematic Review of Observational Studies,” Revista Brasileira de Reumatologia, vol. 56, no. 6, pp. 543-550, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Radhika Parasuram Rajam et al., “Nutraceuticals: A Review,” World Journal of Pharamaceutical Research, vol. 8, no. 11, pp. 1354-1374, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Nahid Akhtar, Mark J. Miller, and Tariq M. Haqqi, “Effect of a Herbal-Leucine Mix on the IL-1β-Induced Cartilage Degradation and Inflammatory Gene Expression in Human Chondrocytes,” BMC Complementary and Alternative Medicine, vol. 11, pp. 1-10, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Samira Kargutkar, and S. Brijesh, “Anti-Rheumatic Activity of Ananas Comosus Fruit Peel Extract in a Complete Freund’s Adjuvant Rat Model,” Pharmaceutical Biology, vol. 54, no. 11, pp. 2616-2622, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Christian R. Engwerda et al., “Bromelain Modulates T Cell and B Cell Immune Responses in Vitro and In-Vivo,” Cellular Immunology, vol. 210, no. 1, pp. 66-75, 2001.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Swarnalatha Dugasani et al., “Comparative Antioxidant and Anti-Inflammatory Effects of Gingerol and Shogaol,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 515-520, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[23] Effie Tjendraputra et al., “Effect of Ginger Constituents and Synthetic Analogues on Cyclooxygenase-2 Enzyme in Intact Cells,” Biooranic Chemistry, vol. 29 no. 3, pp. 156-163, 2001.
[CrossRef] [Google Scholar] [Publisher Link]
[24] S.K. Verma et al., “Protective Effect of Ginger, Zingiber Officinale Rosc on Experimental Atherosclerosis in Rabbits,” Indian Journal of Experimental Biology, vol. 42, no. 7, pp. 736-738, 2004.
[Google Scholar] [Publisher Link]
[25] Eric R. Secor Jr et al., “Bromelain Exerts Anti-Inflammatory Effects in an Ovalbumin-induced Murine Model of Allergic Airway Disease,” Cellular Immunology, vol. 237, no. 1, pp. 68-75, 2005.
[CrossRef] [Google Scholar] [Publisher Link]
[26] R. Hobauer et al., “Garlic Extract (Allium Sativum) Reduces Migration of Neutrophils through Endothelial Cell Monolayers,” Middle East Journal of Anesthesiology, vol. 15, no. 6, pp. 649-658, 2000.
[Google Scholar] [Publisher Link]
[27] Xin Gu, Haishan Wu, and Peiliang Fu, “Allicin Attenuates Inflammation and Suppresses HLA-B27 Protein Expression in Ankylosing Spondylitis Mice,” BioMed Research International, vol. 2013, no. 1, pp. 1-6, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[28] Vladimir N. Drozdov et al., “Influence of a Specific Ginger Combination on Gastropathy Conditions in Patients with Osteoarthritis of the Knee or Hip,” The Journal of Alternative and Complementary Medicine, vol. 18, no. 6, pp. 583-588, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[29] Masoud Haghighi et al., “Comparing the Effects of Ginger (Zingiber Officinale) Extract and Ibuprofen on Patients with Osteoarthritis,” Archives of Iranian Medicine, vol. 8, no. 4, pp. 267-271, 2005.
[Google Scholar] [Publisher Link]
[30] Anousheh Haghighi, Nazfar Tavalaei, and Mohammad Baghar Owlia, “Effects of Ginger on Primary Knee Osteoarthritis,” Indian Journal of Rheumatology, vol. 1, no. 1, pp. 3-7, 2006.
[Google Scholar] [Publisher Link]
[31] R.D. Altman, and K.C. Marcussen, “Effects of a Ginger Extract on Knee Pain in Patients with Osteoarthritis,” Arthritis Rheumatology, vol. 44, no. 11, pp. 2531-2538, 2001.
[CrossRef] [Google Scholar] [Publisher Link]
[32] Sarah Brien et al., “Bromelain as a Treatment for Osteoarthritis: A Review of Clinical Studies,” Evidence-Based Complementary and Alternative Medicine, vol. 1, no. 3, pp. 251-257, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[33] Rajendra Pavan et al., “Properties and Therapeutic Application of Bromelain: A Review,” Biotechnology Research International, vol. 2012, no. 1, pp. 1-6, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[34] H.R. Maurer, “Bromelain: Biochemistry, Pharmacology and Medical Use,” Cellular and Molecular Life Science, vol. 58, pp. 1234-1245, 2001.
[CrossRef] [Google Scholar] [Publisher Link]